Leslie Iltgen

Investor Relations Contact presso HENKEL AG & CO. KGAA

Health Technology

Consumer Non-Durables

Electronic Technology

Profilo

Leslie Iltgen is currently the Head-Investor Relations at Henkel AG & Co. KGaA since 2022.
Prior to this, she held the position of Vice President-Investor Relations at Fresenius SE & Co. KGaA, STADA Arzneimittel AG, and Senior VP-Communications & Investor Relations at DEUTZ AG from 2018 to 2020.
She also worked as a Research Analyst at Bankhaus Lampe KG (Broker).
At Jenoptik AG, she was the Head-Investor Relations & Corporate Communications.

Posizioni attive di Leslie Iltgen

Società	Posizione	Inizio
HENKEL AG & CO. KGAA	Investor Relations Contact	15/09/2022

Tutte le posizioni attive di Leslie Iltgen

Precedenti posizioni note di Leslie Iltgen

Società	Posizione	Fine
DEUTZ AG	Investor Relations Contact	01/12/2020
JENOPTIK AG	Investor Relations Contact	-
FRESENIUS SE & CO. KGAA	Public Communications Contact	-
STADA ARZNEIMITTEL	Investor Relations Contact	-
Bankhaus Lampe KG (Broker)	Analyst-Equity	-

Vedi nel dettaglio l'esperienza di Leslie Iltgen

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Leslie Iltgen

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	4
FRESENIUS SE & CO. KGAA	Health Technology
HENKEL AG & CO. KGAA	Consumer Non-Durables
JENOPTIK AG	Electronic Technology
DEUTZ AG	Producer Manufacturing

Aziende private	2
STADA Arzneimittel AG STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany.	Health Technology
Bankhaus Lampe KG (Broker)	Finance

Aziende private